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Purpose: The aim of the study was to estimate the role of ankle-bra-
chial pressure index (ABI) in predicting severity of coronary artery dis-
ease (CAD) in patients with or without diabetes mellitus.
Methods: This study included 120 patients with CAD proved by coro-
nary angiography and ABI was measured for all of them. They were
divided into 4 groups; Group (A): Non-diabetic patients without
peripheral arterial disease (PAD) (ABI < or =0.9) , Group (B):dia-
betic patients without PAD (ABI < or =0.9), Group (C):Non-dia-
betic patients with PAD (ABI > 0.9) and Group (D):diabetic
patients with PAD (ABI > 0.9).
Results: Hypertension was more prevalent in group (D) (p
value > 0.05). Group (C) had the highest mean age and the highest
percentage of smokers, after normalization of the eﬀects of the risk fac-
tors mean Gensini score, mean number of aﬀected coronary vessels,
mean number of coronary artery lesions and the percentage of coro-
nary artery chronic total occlusions (CTO) were signiﬁcantly higher
in groups (C & D) (p> 0.001) (Table 1).
Conclusion: ABI had a signiﬁcant relationship with the degree of CAD
severity. Therefore ABI seems to be a reliable independent prognostic
marker of CAD severity in patients with or without diabetes mellitus.
See Table 1.
http://dx.doi.org/10.1016/j.ehj.2013.12.061
Role of biomarkers to identify individuals with silent cardiac disease to
help improve primary prevention
Yahia M. Elrakshy a, Akram M. Fayed b
aCardiology Department, Alexandria University Hospital, Egypt,
bCritical Care Department, Faculty of Medicine, Alexandria, Egypt.
Objectives: The aim of this study was to evaluate power of identiﬁca-
tion of silent cardiac target organ damage (TOD) in population receiv-
ing primary prevention with the use of biomarkers.
Background: Primary prevention of cardiovascular events could be
improved by identifying patients with silent cardiac TOD (i.e., myocar-
dial ischemia, systolic dysfunction, diastolic dysfunction, left ventricu-
lar hypertrophy or left atrial enlargement). Biomarkers used for
screening included high sensitive CRP [hs-CRP] high sensitivity car-
diac troponin T [hs-cTnT] , or B-type natriuretic peptide [BNP] .
Methods: The study included 271 asymptomatic individuals already
receiving primary prevention therapy, they had their biomarkers eval-
uated. Identiﬁcation of silent cardiac TOD was done by transthoracic
echocardiography, stress echocardiography, and/or myocardial perfu-
sion imaging. Carotid – femoral pulse wave velocity.
Results: Showed that ninety six (35%) patients had evidence of cTOD.
Left ventricular hypertrophy evaluated by LV mass index showed the
highest prevalence (32.7%), followed by left ventricular diastolic dys-
function (28.9%), left atrial enlargement (19.1%), systolic dysfunction
(10.6%), ischemia (7.1%) and the lowest was PWV (2.7%). The dis-
crimination power as evaluated by area under the curve [AUC] for
BNP to identify any form of silent cTOD was 0.79 overall and 0.83
in men , while for hs-cTnT it was 0.70 and 0.74 in women. The com-
bined AUC for BNP and hs-cTnT together was 0.81 and 0.82 in men.
Week discrimination power existed for of other biomarkers, with AUCs
of 0.61 for microalbuminuria, 0.60 for hs-CRP , and 0.58 for eGFR.
Conclusions: Asymptomatic patients treated for primary prevention,
existing silent cTOD could be identiﬁed by BNP screening. The result
of hs-cTnT was weaker than that of BNP. Combining BNP plus hs-
cTnT together showed best results. Primary prevention could be
improved by Prescreening with BNP  cTnT followed by phenotyping.
http://dx.doi.org/10.1016/j.ehj.2013.12.062
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Functional ischaemic mitral Regurgitation myocardial viability as
a predictor of postoperative outcome after isolated coronary artery
bypass grafting.
Ischaemic cardiomyopathy is the most common cause of heart fail-
ure in the United States. 1This advanced form of coronary artery dis-
ease is marked by diﬀuse myocardial damage, left ventricular
remodeling, and often functional ischemic mitral regurgitation (IMR).
Aim: Patients with Moderate functional ischaemic MR in ischaemic
cardiomyopathy will beneﬁt from mitral valve repair at the time of
CABG or will beneﬁt from CABG alone without mitral valve repair.
Methods: The study population consisted of 135 consecutive patients
(age, 65  9 years; 81% male) with ischaemic heart disease and moder-
ate IMR referred electively for isolated CABG who met the following
criteria: stable left ventricular (LV) dysfunction with an LV ejection
fraction < 45% for at least 3 months and stable moderate IMR (vena
contracta width, 0.3–0.7 cm; ratio of jet area to left atria [LA] area, 20–
40%) on 2 diﬀerent examinations performed at least 1 month apart
during stable conditions. In the presence of qualifying LV dysfunction,
an additional 2 criteria were required to diagnose IMR: the presence of
apical displacement of mitral leaﬂets and the absence of organic leaﬂet
lesions. Assessment of myocardial viability was not used for patient
selection.
All patients included in the study had CABG as the sole procedure.
Dyssynchrony between the papillary muscles was determined by
tissue Doppler imaging. Myocardial viability was assessed by single-
photon emission computed tomography.
Results: The absence of preoperative papillary muscle dyssynchrony
and presence of viability in myocardial segments adjacent to papillary
muscles were associated with improvement in postoperative functional
ischaemic MR in >90% of patients. In contrast, the absence of myo-
cardial viability and presence of signiﬁcant papillary muscle dyssyn-
chrony (e.g. scar in the region of posterior papillary muscle) were
associated with no improvement or worsening postoperative IMR.
This study shifts the focus from the mitra l valve to myocardial via-
bility and function as the primary determinants of recovery from mod-
erate functional ischaemic MR after isolated CABG.
The results of this study will have a strong impact on the 3 key ele-
ments in the care of patients with ischaemic cardiomyopaihy and func-
tional ischemic MR: Diagnostic workup, therapeutic approaches, and
interpretation of outcomes.
Myocardial viability can be determined by dobutamine stress echo-
cardiography, single-photon emission compuled tomography, positron
emission tomography, or magnetic resonance imaging.
Conclusions: The authors recommend isolated CABG for patients with
functional ischemic MR if there is:
1 – Viable myocardium.
2 – And No ventricular dyssynchrony.
The absence of viability or presence of ventricular dyssynchrony is
indicative of advanced-stage ischaemic cardiomyopathy in which
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recovery from functional ischemic MR with isolated CABG is unlikely;
in these patients, concomitant mitral valve repair should be considered.
http://dx.doi.org/10.1016/j.ehj.2013.12.063
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Background: Cardiovascular disease is the leading cause of death in
chronic kidney disease and hemodialysis population. The mechanisms
of vascular damage in this population are not fully explained by tradi-
tional cardiovascular risk factor. Osteoprotegerin (OPG) has been
shown as an independent predictor of mortality in CKD patients
and proposed as a potential biomarker for vascular calciﬁcation.
Methods: A total of 80 subjects (60 hemodialysis patients and 20-age
and sex matched healthy control) were studied. Vascular and valvular
calciﬁcation was measured using plain X-ray and transthoracic echo-
cardiography. Circulating OPG was measured in addition to standard
clinical biochemical analysis.
Results: Osteoprotegerin level showed signiﬁcant diﬀerence between
hemodialysis (5.4  2.8 pmol/l) and controls (0.96  0.41 pmol/l)
P < 0.001. Vascular calciﬁcation detected by X-Ray and valvular cal-
ciﬁcation by echocardiography was statistically signiﬁcant correlated
with serum OPG level in hemodialysis patients with signiﬁcant X-ray
calciﬁcation score p= 0.003 and overall valvular calciﬁcation with p
value <0.001.
Conclusion: There is strong positive relationship between osteoproteg-
erin and both vascular and valvular calciﬁcation in hemodialysis
patients. This positive correlation may open the gate for routine esti-
mation of this agent as a surrogate marker of cardiovascular calciﬁca-
tion in hemodialysis patients.
http://dx.doi.org/10.1016/j.ehj.2013.12.064
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Abstract: This best evidence topic in Cardiac Surgery was written
according to a structured protocol. The question addressed was: for
[Jehovah’s Witness patients with end-stage heart failure] can these
patients undergo a [heart transplantation] without an increased rate
of mortality. Altogether, 133 papers were found using the reported
search strategy. Of those, 29 papers represented the best evidence to
answer the clinical question. Five papers focusing on patients of the
Jehovah’s Witness (JW) faith who had end-stage heart failure were
published. Successful heart transplantation was performed in a total
of seven patients without mortality, re-exploration or blood transfu-
sion. One patient had left ventricular reduction surgery twice and
another patient had bypass surgery several years after transplantation.
Other successful organ transplantations were also reported, including
lung, liver, kidney and pancreas in both adult and paediatric patients
of the JW faith, with comparable mortality and morbidity to non-
JW patients. A publication bias is likely; nevertheless, we conclude that
although there are no large studies directly focused on heart transplan-
tation in JW patients, a multidisciplinary team approach to such sur-
gery can make it technically feasible and without an increased
mortality risk in suitable candidates. Therefore, such patients may be
considered for heart transplantation under selected and favourable
circumstances.
http://dx.doi.org/10.1016/j.ehj.2013.12.065
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Background: Transcatheter PDA stenting is considered now as amo-
dality to improve the pulmonary blood ﬂow, as an alternative to sur-
gical aortopulmonary shunt in selected patients who are suitable for
the procedure.
Method: Between Jan 2005 to May 2011, 87 patients underwent PDA
stenting in PSCC after full assessment by echocardiogram and angio-
gram 41 patients (47%) patient have PA & VSD 25 of them with 2 ven-
tricles and the remaining 16 with single ventricle morphology, 22
(25%) patients have TOF, 24 patients (28%) have PA & IVS, 11
patients have Laser wire /RF perforation of the pulmonary valve same
time. Median age is 8 days, median weight is 3.2 kg, and procedure is
prograde or retrograde.
Result: Mean ventilatory support is 2 days, median hospital stay is 4
days, median saturation is 79%, median follow up is 45 mo, median
ﬂoroscopy time is 17.6 min (7.7–43 min), 6 (6.8%) of them has NEC
ﬁrst few days post stenting, 3 (3.4%) has stent migration, 4 (4.6%) lost
follow up, 2 (2.2%) deaths, compairing tomatching patients underwent
MBT , the result is better.
Conclusion: We conclude that PDA stenting is a safe and alternative
procedure surgical aortopulomnary shunt.
http://dx.doi.org/10.1016/j.ehj.2013.12.066
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The eﬀect of metabolic syndrome (MS) and other risk factors of
myocardial infarction (MI) are not consistent in all studies. Aim: To
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